Cytek Biosciences Inc. (CTKB) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cytek Biosciences Inc., updated every trading day.
Industrials · Biotechnology: Laboratory Analytical Instruments
Price
$6.14
+2.68% today
Market cap
$777M
Overall quality
49/100
Kronos AI 30-day
−23.7%
0 of 8 simulated paths end higher
Cytek Biosciences Inc. (CTKB) is a Industrials company in Biotechnology: Laboratory Analytical Instruments, worth $777M. It trades at $6.14, up 2.68% today. Its overall quality score is 49 out of 100, ranked against the whole US market. 4 analysts' average target of $5.88 implies −4.2% from today's price. Kronos AI's 30-day forecast is −23.7% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $5.88 |
| Low – high | $5.00 – $7.50 |
| Analysts | 4 |
| Upside to average | −4.2% |
Kronos AI 30-day forecast
| Expected close | $4.56 (−23.7%) |
| Likely range | −29.9% … −20.9% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 34 |
| Solvency | 76 |
| Growth | 38 |
| Overall | 49 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Laboratory Analytical Instruments
For information only, not investment advice. Prices updated: 2026-10-29.